SCHEMBL16488274

SCHEMBL16488274

C[C@H](n1nnc2ccccc21)C(C)(C)C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC9A1 P19634 8/20 0.48
KEAP1 Q14145 1/20 0.48
ALDH1A1 P00352 2/20 0.44
CYP1A2 P05177 2/20 0.44
POLB P06746 2/20 0.44
MAPK1 P28482 1/20 0.44
ATM Q13315 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
MAPT P10636 1/20 0.44
CYP2C9 P11712 1/20 0.44
THPO P40225 1/20 0.44
CYP4Z1 Q86W10 1/20 0.44
CYP2C19 P33261 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
APAF1 O14727 1/20 0.42
DGAT1 O75907 1/20 0.41
HSD17B10 Q99714 1/20 0.39
GRM2 Q14416 1/20 0.39
PTPN2 P17706 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24422508 0.81 SLC9A1 (0.52) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL14149860 0.81 SLC9A1 (0.52) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL1083846 0.81 ALDH1A1 (0.58) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL9220916 0.81 SLC9A1 (0.55) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL14422298 0.81 SLC9A1 (0.55) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL28458742 0.81 SLC9A1 (0.47) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL4221863 0.79 SLC9A1 (0.48) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL1866263 0.78 SLC9A1 (0.52) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL4222237 0.78 SLC9A1 (0.52) SLC9A1KEAP1ALDH1A1CYP1A2POLB
SCHEMBL17676626 0.78 SLC9A1 (0.52) SLC9A1KEAP1ALDH1A1CYP1A2POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2492261-B1 Analogs of benzoquinone-containing ansamycins for the treatment of cancer INFINITY DISCOVERY INC (US) 2015-02-18 EP disclosed